Nu-Med Plus (NUMD) Shares Outstanding (2011 - 2025)

Nu-Med Plus has reported Shares Outstanding (Entity) for 15 years, with the latest figure at $83.5 million in Q4 2025.

• Quarterly Shares Outstanding (Entity) changed 0.0% year-over-year to $83.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $83.5 million (changed 0.0% YoY) and the FY2025 annual result came in at $83.5 million, changed 0.0% from the prior year.
• Shares Outstanding (Entity) held at $83.5 million in Q4 2025 per NUMD's latest filing, from $83.5 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $83.5 million in Q4 2023 and troughed at $79.3 million in Q1 2021.
• A 5-year average of $81.7 million and a median of $81.3 million in 2022 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2021 and 2022: Shares Outstanding (Entity) jumped 78.4% in 2021, then changed 0.0% in 2022.
• Over 5 years, Shares Outstanding (Entity) stood at $79.3 million in 2021, then increased by 2.52% to $81.3 million in 2022, then advanced by 2.7% to $83.5 million in 2023, then changed by 0.0% to $83.5 million in 2024, then changed by 0.0% to $83.5 million in 2025.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $83.5 million, $83.5 million, and $83.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.